Outcome of Patients with Chronic Myeloid Leukemia After Allogeneic Stem Cell Transplantation in Europe; Data From the EUTOS for CML Registry

被引：0

作者：

Saussele, Susanne ^{[1
]}

Hoffmann, Verena ^{[2
]}

Lindoerfer, Doris ^{[2
]}

Hochhaus, Andreas ^{[3
]}

Cervantes, Francisco ^{[4
]}

Ossenkoppele, Gert ^{[5
]}

Hjorth-Hansen, Henrik ^{[6
]}

O'Brien, Steve ^{[7
]}

Mayer, Jiri ^{[8
]}

Indrak, Karel ^{[9
]}

Hellmann, Andrzej ^{[10
]}

Colita, Adriana

Turkina, Anna ^{[11
]}

Zaritskey, Andrey ^{[12
]}

Luis Steegmann, Juan ^{[13
]}

Marin, David ^{[14
]}

Pfirrmann, Markus ^{[2
]}

Baccarani, Michele ^{[15
]}

Guilhot, Joelle ^{[16
]}

Hasford, Joerg ^{[2
]}

Piccolo, Carmen ^{[17
]}

Simonsson, Bengt ^{[18
]}

Hehlmann, Ruediger ^{[1
]}

Rosti, Gianantonio ^{[19
]}

机构：

[1] Univ Heidelberg, Med Fak Mannheim, Med Klin 3, D-6800 Mannheim, Germany

[2] Univ Munich, Inst Med Informat & Biometry, Munich, Germany

[3] Univ Klinikum Jena, Jena, Germany

[4] Hosp Clin Barcelona, Dept Hematol, Barcelona, Spain

[5] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands

[6] Norwegian Univ Sci & Technol, Trondheim, Norway

[7] Newcastle Univ, Dept Hematol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England

[8] Univ Hosp Brno, Dept Haematol Oncol, Brno, Czech Republic

[9] Univ Hosp, Dept Hematooncol, Olomouc, Czech Republic

[10] Med Univ Gdansk, Dept Hematol & Transplantol, Gdansk, Poland

[11] Natl Res Ctr Hematol, Moscow, Russia

[12] VA Almazov, Ctr Heart Blood & Endocrinol, St Petersburg, Russia

[13] Hosp Univ Princesa, Dept Hematol, Madrid, Spain

[14] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Hematol, London, England

[15] Univ Bologna, Dept Hematol Oncol L&A Seragnoli, Bologna, Italy

[16] CHU Poitiers, INSERM, CIC 0802, Poitiers, France

[17] Novartis GmbH, Origgio, Italy

[18] Univ Uppsala Hosp, Dept Med, Uppsala, Sweden

[19] Univ Bologna, Dept Hematol & Oncol L&A Seragnoli, Bologna, Italy

来源：

BLOOD | 2011年 / 118卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：733 / 734

页数：2

共 50 条

[31] Allogeneic stem cell transplantation for chronic myeloid leukemia–status in 2007 [J].

J M Goldman .

Bone Marrow Transplantation, 2008, 42 :S11-S13

[32] Stem Cell Transplantation for Chronic Myeloid Leukemia (CML): Current Indications and Perspectives [J].

Bacigalupo, Andrea .

CURRENT CANCER DRUG TARGETS, 2013, 13 (07) :775-778

[33] Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML [J].

Christian Niederwieser ;

Elena Morozova ;

Ludmila Zubarovskaya ;

Tatjana Zabelina ;

Evgeny Klyuchnikov ;

Dietlinde Janson ;

Christine Wolschke ;

Maximilian Christopeit ;

Francis Ayuk ;

Ivan Moiseev ;

Boris V. Afanasyev ;

Nicolaus Kröger .

Bone Marrow Transplantation, 2021, 56 :2834-2841

[34] Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML [J].

Niederwieser, Christian ;

Morozova, Elena ;

Zubarovskaya, Ludmila ;

Zabelina, Tatjana ;

Klyuchnikov, Evgeny ;

Janson, Dietlinde ;

Wolschke, Christine ;

Christopeit, Maximilian ;

Ayuk, Francis ;

Moiseev, Ivan ;

Afanasyev, Boris V. ;

Kroger, Nicolaus .

BONE MARROW TRANSPLANTATION, 2021, 56 (11) :2834-2841

[35] Characterisation of extramedullary relapse in patients with chronic myeloid leukemia in advanced disease after allogeneic stem cell transplantation [J].

Ocheni, Sunday ;

Iwanski, Gabriela B. ;

Schafhausen, Philippe ;

Zander, Axel Rolf ;

Ayuk, Francis ;

Klyuchnikov, Evgeny ;

Zabelina, Tatjana ;

Fiedler, Walter ;

Schnittger, Susanne ;

Hochhaus, Andreas ;

Bruemmendorf, Tim H. ;

Kroeger, Nicolaus ;

Bacher, Ulrike .

LEUKEMIA & LYMPHOMA, 2009, 50 (04) :551-558

[36] Significance of Minimal Residual Disease in Patients with Chronic Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation [J].

Solarska, Iwona ;

Nasilowska-Adamska, Barbara ;

Bieniaszewska, Maria ;

Zaucha, Jan Maciej ;

Rzepecki, Piotr ;

Sawicki, Waldemar ;

Calbecka, Malgorzata ;

Lech-Maranda, Ewa ;

Marianska, Bozena ;

Warzocha, Krzysztof .

BLOOD, 2009, 114 (22) :1266-1266

[37] Allogeneic Stem Cell Transplantation for Patients with Chronic Myeloid Leukemia After Prior Treatment with Nilotinib or Dasatinib. [J].

Schleuning, Michael ;

Scholten, Marijke ;

van Biezen, Anja ;

Nagler, Arnon ;

Apperley, Jane F. ;

Michallet, Mauricette ;

Grigg, Andrew ;

Silver, Richard T. ;

Leitner, Armin ;

Gratwohl, Alois ;

Ekblom, Maria ;

Khoury, H. Jean ;

de Witte, Theo ;

Olavarria, Eduardo .

BLOOD, 2010, 116 (21) :970-970

[38] Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemia [J].

Devillier, Raynier ;

Crocchiolo, Roberto ;

Etienne, Anne ;

Prebet, Thomas ;

Charbonnier, Aude ;

Fuerst, Sabine ;

El-Cheikh, Jean ;

D'Incan, Evelyne ;

Rey, Jerome ;

Faucher, Catherine ;

Blaise, Didier ;

Vey, Norbert .

LEUKEMIA & LYMPHOMA, 2013, 54 (06) :1228-1234

[39] Is Allogeneic Transplantation an Option in Patients Affected by Concurrent Myelofibrosis and Chronic Myeloid Leukemia (CML)? [J].

Sora, Federica ;

Chiusolo, Patrizia ;

Autore, Francesco ;

Giammarco, Sabrina ;

Laurenti, Luca ;

Metafuni, Elisabetta ;

Innocenti, Idanna ;

Galli, Eugenio ;

Bacigalupo, Andrea ;

Sica, Simona .

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2021, 13

[40] Allogeneic hematopoietic stem cell transplantation (HSCT) for chronic myeloid leukemia (CML) patients in the TKI-era: A single center experience [J].

Schmidt, E. ;

Groth, C. ;

Mikesch, J. -H. ;

Reicherts, C. ;

Mesters, R. ;

Schliemann, C. ;

Kessler, T. ;

Kerkhoff, A. ;

Kropff, M. ;

Lenz, G. ;

Berdel, W. E. ;

Stelljes, M. .

ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 :144-144

← 1 2 3 4 5 →